Difference between revisions of "MR Coordinating Committee"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
:Chairs: Michael Boss, PhD (Co-Chair); Mark Rosen, MD, PhD (Co-Chair); Gudrun Zahlmann, PhD (Co-chair); Cathy Elsinger, PhD (Vice-chair) | :Chairs: Michael Boss, PhD (Co-Chair); Mark Rosen, MD, PhD (Co-Chair); Gudrun Zahlmann, PhD (Co-chair); Cathy Elsinger, PhD (Vice-chair) | ||
| − | : | + | :RSNA Staff Support: Susan Stanfa |
[https://tinyurl.com/QIBA-MR-CC-Roster Roster] | [https://tinyurl.com/QIBA-MR-CC-Roster Roster] | ||
Revision as of 16:41, 22 May 2019
- Chairs: Michael Boss, PhD (Co-Chair); Mark Rosen, MD, PhD (Co-Chair); Gudrun Zahlmann, PhD (Co-chair); Cathy Elsinger, PhD (Vice-chair)
- RSNA Staff Support: Susan Stanfa
Scope
The MR Coordinating Committee coordinates Biomarker Committees based on MR.
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the MR Biomarker Committees
Meetings
- Tcons are held Quarterly. Contact the secretary for details.